Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
0.2420
+0.0085 (3.64%)
At close: Jan 9, 2026, 4:00 PM EST
0.2500
+0.0080 (3.31%)
After-hours: Jan 9, 2026, 7:02 PM EST
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $6.45 million as of January 9, 2026. Its market cap has decreased by -5.91% in one year.
Market Cap
6.45M
Enterprise Value
1.90M
1-Year Change
-5.91%
Ranking
Category
Stock Price
$0.24
Market Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.34M to $6.45M, a decrease of -75.51%. That is a compound annual growth rate of -17.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 6.22M | 6.14% |
| Dec 31, 2025 | 5.86M | -10.34% |
| Dec 31, 2024 | 6.54M | 188.66% |
| Dec 29, 2023 | 2.27M | -60.76% |
| Dec 30, 2022 | 5.77M | -89.79% |
| Dec 31, 2021 | 56.56M | 131.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 30, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.72B |
| Johnson & Johnson | 493.40B |
| AbbVie | 395.77B |
| UnitedHealth Group | 316.11B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.22B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |